Product Information
LAMOTRIGINE ER 300 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.2133 per EA under NDC 49884060511. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Endo USA Inc.NDC
49884060511
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA201791On Market Since
1/18/2013
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ER 300 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 92.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2133 per EA |
|---|---|
| All-time high | $15.4329 (Dec 11, 2013) |
| All-time low | $0.9867 (Nov 20, 2024) |
| 52-week high | $1.4630 |
| 52-week low | $1.2016 |
| Median price | $4.9802 |
| Average price | $6.3027 |
| Largest weekly change | +59.8% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lamotrigine extended release market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 300 MG TABLET, manufactured by Endo USA Inc., is $1.2133 per EA (NDC 49884060511), effective Jun 24, 2026.
How has the price of LAMOTRIGINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ER 300 MG TABLET has declined 92.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 300 MG TABLET?
Since Nov 28, 2013, the NADAC for LAMOTRIGINE ER 300 MG TABLET has ranged from a low of $0.9867 (Nov 20, 2024) to a high of $15.4329 (Dec 11, 2013), with a median of $4.9802 per EA.
Are there cheaper alternatives to LAMOTRIGINE ER 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LAMOTRIGINE ER 300 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures LAMOTRIGINE ER 300 MG TABLET?
LAMOTRIGINE ER 300 MG TABLET (NDC 49884060511) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification